Rheumatology NewsSubcutaneous high-dose methotrexate controls psoriasisFebruary 8, 2017Psoriatic Arthritis
Rheumatology NewsPerioperative infliximab does not increase serious infection riskFebruary 6, 2017Rheumatoid ArthritisOrthopedicsPsoriatic ArthritisSpondyloarthropathiesAnkylosing spondylitis
Rheumatology NewsVIDEO: Interchangeability of biosimilars and parent compounds raise potential efficacy issuesJanuary 29, 2017Psoriatic Arthritis
Rheumatology NewsFDA opens abbreviated approval pathway for interchangeable biosimilarsJanuary 26, 2017SpondyloarthropathiesPsoriatic ArthritisRheumatoid ArthritisAnkylosing spondylitis
Rheumatology NewsBone fractures more likely to occur in psoriasis, PsA patientsJanuary 24, 2017Psoriatic ArthritisOsteoporosis
Rheumatology NewsSymptoms don’t worsen during pregnancy in most PsA patientsJanuary 23, 2017Psoriatic Arthritis
Rheumatology NewsFixed combination topical shows promise for psoriasisJanuary 19, 2017Psoriatic Arthritis
Rheumatology NewsChildhood psoriasis negatively impacts parental QOLJanuary 19, 2017Psoriatic Arthritis
Rheumatology NewsMedicare payments set for infliximab biosimilar InflectraJanuary 10, 2017Rheumatoid ArthritisAnkylosing spondylitisPsoriatic ArthritisSpondyloarthropathies
Rheumatology NewsInitial suboptimal responders to secukinumab usually bloom laterDecember 21, 2016Psoriatic Arthritis
Rheumatology NewsIxekizumab proves highly effective for palmoplantar, scalp psoriasisDecember 21, 2016Psoriatic Arthritis
Rheumatology NewsLatest ixekizumab safety data called ‘very reassuring’December 13, 2016Psoriatic Arthritis
